Skip to main content
Kimberly-ClarkAcquisition

Kimberly-Clark Acquires Kenvue to Strengthen Consumer Health Portfolio

What happened

Kimberly-Clark Corporation is acquiring Kenvue Inc., the former consumer health business of Johnson & Johnson, to strengthen its consumer health portfolio.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Kimberly-Clark Corporation is acquiring Kenvue Inc., the former consumer health business of Johnson & Johnson, as reported by Detik Finance from CNBC's Mad Money episode on Tuesday. The move establishes a defensive holding for investors reallocating from volatile technology stocks into lower-risk value assets. The strategic acquisition grants Kimberly-Clark control over widely used consumer health staples, including Tylenol, Neutrogena, Listerine, and Band-Aids. According to host Jim Cramer, the transaction provides a steady cash flow stream and a bottom for the stock after extended price struggles. "This one's finally found its footing after struggling for years. Best of all, Kimberly-Clark realized it needs to consolidate, which is why it's acquiring Kenvue, J&J's old consumer health business. I want you to think there… Tylenol, Neutrogena, Listerine, Band-Aids. These are everyday necessities that consumers buy regardless of the state of the economy or the price of gasoline. Doesn't hurt that Kimberly-Clark will pay you handsomely while you wait for the deal to close," said Jim Cramer, Host of CNBC's Mad Money. The combination offers potential long-term revenue growth, improved operating margins, and structural cost reductions. It also serves as a safeguard against foreign competition by leveraging constant demand for health and wellness products regardless of broader fuel...

Keep reading with a free account

The rest of this article, and every signal for Kimberly-Clark, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Acquisition

What this signalsIntegration work after a deal often opens needs for new systems and services.

More acquisition signals at other companies

The full record

From the Signal API record

Extraction

Confidence
95%
Detected
Jul 25, 2026
signal_type
news
signal_subtype
acquires

Use this data

Get every acquisition signal for Kimberly-Clark and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Kimberly-Clark this week?”

  2. Send it to your own tools

    The Signal API returns acquisition signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/3a79ecfa-e8b9-fc4b-fd80-8ae973e3a2e9 returns this record as JSON. POST /v1/companies/enrich returns every signal for kimberly-clark.com.

{
  "signal_id": "3a79ecfa-e8b9-fc4b-fd80-8ae973e3a2e9",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-07-25T14:00:22+00:00",
  "company": {
    "name": "Kimberly-Clark",
    "domain": "kimberly-clark.com"
  },
  "data": {
    "url": "https://www.sekbernews.id/en/kimberly-clark-acquires-kenvue-consumer-health",
    "title": "Kimberly-Clark Acquires Kenvue to Strengthen Consumer Health Portfolio - sekbernews.id",
    "excerpt": "Kimberly-Clark Corporation is acquiring Kenvue Inc., the former consumer health business of Johnson & Johnson, as reported by Detik Finance from CNBC's Mad Money episode on Tuesday. The move establishes a defensive holding for investors reallocating from volatile technology stocks into lower-risk value assets. The strategic acquisition grants Kimberly-Clark control over widely used consumer health staples, including Tylenol, Neutrogena, Listerine, and Band-Aids. According to host Jim Cramer, the transaction provides a steady cash flow stream and a bottom for the stock after extended price struggles. \"This one's finally found its footing after struggling for years. Best of all, Kimberly-Clark realized it needs to consolidate, which is why it's acquiring Kenvue, J&J's old consumer health business. I want you to think there… Tylenol, Neutrogena, Listerine, Band-Aids. These are everyday necessities that consumers buy regardless of the state of the economy or the price of gasoline. Doesn't hurt that Kimberly-Clark will pay you handsomely while you wait for the deal to close,\" said Jim Cramer, Host of CNBC's Mad Money. The combination offers potential long-term revenue growth, improved operating margins, and structural cost reductions. It also serves as a safeguard against foreign competition by leveraging constant demand for health and wellness products regardless of broader fuel...",
    "summary": "Kimberly-Clark Corporation is acquiring Kenvue Inc., the former consumer health business of Johnson & Johnson, to strengthen its consumer health portfolio.",
    "planning": true,
    "image_url": "https://cdn.sekbernews.id/media/images/2026/07/fB2PHh4T4u.jpeg?location=1&width=1200&height=674&quality=80&watermark=1",
    "confidence": 0.95,
    "published_at": "2026-07-25T14:00:22Z",
    "article_sentence": "Kimberly-Clark Corporation is acquiring Kenvue Inc., the former consumer health business of Johnson & Johnson, as reported by Detik Finance from CNBC's Mad Money episode on Tuesday.",
    "related_company_name": "Kenvue",
    "related_company_domain": "kenvue.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.